Deutsche Bank Reiterates a 'Buy' on Five Below (FIVE); Raising Estimates on Strong Q2
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Pre-Open Movers 9/11: (WSM) (SNSS) (CASY) Higher; (NAVB) (PPO) (SQNM) Lower (more...)
September 11, 2012 9:31 AM EDTWSB Holdings, Inc.(NASDAQ: WSB) 91% HIGHER ; acquired by Old Line Bancshares (NASDAQ: OLBK).
Sunesis Pharma (NASDAQ: SNSS) 47% HIGHER ; to Boost Sample Size in Phase 3 VALOR of Vosaroxin in AML
Navidea Biopharmaceuticals, Inc (NASDAQ:... More
Jefferies Maintains a 'Buy' on Five Below (FIVE); Solid Start
September 11, 2012 7:17 AM EDTJefferies maintains a 'Buy' on Five Below (NASDAQ: FIVE) price target of $40.00.
Analyst, Daniel Binder, said, "FIVE showed a strong quarter with an 8.6% SSS increase, healthy gross margin expansion and modest expense leverage. We think that the stock could show initial weakness as... More
After-Hours Movers 9/10: (CASY) (GMCR) Higher; (NAVB) (PANW) (SQNM) Lower (more...)
September 10, 2012 5:51 PM EDTNavidea Biopharmaceuticals, Inc (NASDAQ: NAVB) 35% LOWER ; The FDA does not approve Lymphoseek, co. receives CRL.
Voyager Oil & Gas, (AMEX: EOX) 12% LOWER ; commenced... More
Five Below (FIVE) Tops Q2 EPS by 3c; Guides Q3, FY12 EPS, Sales
September 10, 2012 4:07 PM EDTFive Below (NASDAQ: FIVE) reported Q2 EPS of $0.04, $0.03 better than the analyst estimate of $0.01. Revenue for the quarter came in at $86.8 million versus the consensus estimate of $81.95 million.
Five Below sees Q3 2012 EPS of $0.00-0.01, versus the consensus of $0.00 and revenue of $79-81... More
Trading Radar for 09/10: Palo Alto (PANW), Five Below (FIVE), Titan Machinery (TITN), Peregrine Pharma (PPHM) Report
September 7, 2012 4:38 PM EDTThe Trading Radar highlights key earnings and economic announcements for tomorrow's trading session:
Before The Market Opens
Earnings:
Peregrine Pharmaceuticals (Nasdaq: PPHM) - consensus loss $0.11
Titan Machinery (Nasdaq: TITN) - consensus EPS $0.43
... More
